-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FGjL6AhFekBa9wgQQ1Oty6rqXP7quA+BlcfrNYdEsl78WW7U8M2Gc6f2Hqi4WMNN lR/B4HBh+r14bvv7dsz4ow== 0000950148-99-000866.txt : 19990419 0000950148-99-000866.hdr.sgml : 19990419 ACCESSION NUMBER: 0000950148-99-000866 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990416 GROUP MEMBERS: ALAN WALTER GILBERT GROUP MEMBERS: BELLINGHAM INDUSTRIES INC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROXYMED INC /FT LAUDERDALE/ CENTRAL INDEX KEY: 0000906337 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 650202059 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-45897 FILM NUMBER: 99595748 BUSINESS ADDRESS: STREET 1: 2555 DAVIE ROAD STREET 2: SUITE 110 CITY: FORT LAUDERDALE STATE: FL ZIP: 33317-7424 BUSINESS PHONE: 9544731001 FORMER COMPANY: FORMER CONFORMED NAME: HMO PHARMACY INC DATE OF NAME CHANGE: 19930601 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BELLINGHAM INDUSTRIES INC CENTRAL INDEX KEY: 0001032279 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 000000000 STATE OF INCORPORATION: R1 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: PO BOX 312 13 ROYAL SQUARE STREET 2: ST HELIER, JERSEY, CHANNEL ISLANDS CITY: UNITED KINGDOM STATE: X0 BUSINESS PHONE: 011441883652550 MAIL ADDRESS: STREET 1: PO BOX 312 13 ROYAL SQUARE STREET 2: ST HELIER, JERSEY, CHANNEL ISLANDS CITY: UNITED KINGDOM STATE: X0 SC 13D/A 1 SCHEDULE 13D/AMENDMENT 18 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 18)* PROXYMED, INC. ------------------------------------------------------------------------------ (Name of Issuer) Common Stock, $.001 par value ------------------------------------------------------------------------------ (Title of Class of Securities) 744290107 ------------------------------------------------------------------------------ (CUSIP Number) W.R. Gilbert, P.O. Box 323, 13 Royal Square, St. Helier, Jersey, Channel Islands, United Kingdom, Tel: 011 44 1883 652 550 ------------------------------------------------------------------------------ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 1, 1998 ------------------------------------------------------------------------------ (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box [ ]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) 2 CUSIP NO. 744290107 13D Page 2 of 5 Pages - ------------------------------------------------------------------------------ (1) Names of Reporting Persons I.R.S. Identification Nos. of Above Persons (entities only) Bellingham Industries, Inc. - ------------------------------------------------------------------------------ (2) Check the Appropriate Box if a Member (a) [ ] of a Group (See Instructions) (b) [ ] - ------------------------------------------------------------------------------ (3) SEC Use Only - ------------------------------------------------------------------------------ (4) Source of Funds (See Instructions) WC - ------------------------------------------------------------------------------ (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------ (6) Citizenship or Place of Organization Panama - ------------------------------------------------------------------------------ Number of Shares (7) Sole Voting Power Beneficially Owned 6,554,842 shares by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power -------------------------------------------------- (9) Sole Dispositive Power 6,554,842 shares -------------------------------------------------- (10) Shared Dispositive Power - ------------------------------------------------------------------------------ (11) Aggregate Amount Beneficially Owned by Each Reporting Person 6,554,842 shares - ------------------------------------------------------------------------------ (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - ------------------------------------------------------------------------------ (13) Percent of Class Represented by Amount in Row (11) 42.04% - ------------------------------------------------------------------------------ (14) Type of Reporting Person (See Instructions) CO - ------------------------------------------------------------------------------ 3 CUSIP NO. 744290107 13D Page 3 of 5 Pages - ------------------------------------------------------------------------------ (1) Names of Reporting Persons I.R.S. Identification Nos. of Above Persons (entities only) Alan Walter Gilbert - ------------------------------------------------------------------------------ (2) Check the Appropriate Box if a Member (a) [ ] of a Group (See Instructions) (b) [ ] - ------------------------------------------------------------------------------ (3) SEC Use Only - ------------------------------------------------------------------------------ (4) Source of Funds (See Instructions) WC of Bellingham Industries, Inc. - ------------------------------------------------------------------------------ (5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------ (6) Citizenship or Place of Organization United Kingdom - ------------------------------------------------------------------------------ Number of Shares (7) Sole Voting Power Beneficially Owned 6,554,842 shares by Each Reporting -------------------------------------------------- Person With (8) Shared Voting Power -------------------------------------------------- (9) Sole Dispositive Power 6,554,842 shares -------------------------------------------------- (10) Shared Dispositive Power - ------------------------------------------------------------------------------ (11) Aggregate Amount Beneficially Owned by Each Reporting Person 6,554,842 shares - ------------------------------------------------------------------------------ (12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - ------------------------------------------------------------------------------ (13) Percent of Class Represented by Amount in Row (11) 42.04% - ------------------------------------------------------------------------------ (14) Type of Reporting Person (See Instructions) IN - ------------------------------------------------------------------------------ 4 CUSIP NO. 744290107 13D Page 4 of 5 Pages This Amendment No. 18 amends and supplements the Statement on Schedule 13D (the "Schedule 13D") relating to the common stock, $.001 par value per share (the "Common Stock"), of ProxyMed, Inc., a Florida corporation (the "Company"), previously filed by Bellingham Industries, Inc. and Alan Walter Gilbert (the "Reporting Persons"). Except as specifically provided herein, this Amendment does not modify any of the information previously reported in the Schedule 13D. ITEM 4. PURPOSE OF TRANSACTION On May 21, 1998, shareholders of the Company elected Peter A. A. Saunders, F.R.S.A. (Fellow of Royal Society of Arts) a director of the Company. The Company nominated Mr. Saunders as a director at Bellingham's request; however, the Reporting Persons have no agreement with the Company, written or oral, which would grant them any legal right to nominate or designate Mr. Saunders, or any other person, for election or appointment to the Company's Board of Directors. Bellingham's ability to influence the management and policies of the Company is increased by the fact that Mr. Saunders serves as one of the Company's seven directors. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER Item 5 of the Schedule 13D is hereby amended to add the following information: As a result of the purchases described below, on June 1, 1998 the Reporting Persons were the beneficial owners of 6,554,842 shares of the Company's Common Stock (including 250,000 shares of the Company's Common Stock issuable upon exercise of warrants held by the Reporting Persons (the "Warrants")) and had sole voting and investment power with respect to all such shares. Based upon information presented in the Company's quarterly report on Form 10-Q for the quarter ended March 31, 1998 and information otherwise available to the Reporting Persons, on June 1, 1998 there were approximately 15,590,120 shares of the Company's Common Stock outstanding (assuming that all of the Warrants had been exercised) and the Reporting Persons beneficially owned 42.04% of that total. Based on the Company's annual report on Form 10-K for the year ended December 31, 1998, on March 5, 1999 the Company had approximately 18,068,372 shares of Common Stock outstanding (assuming that all of the Warrants had been exercised), and the Reporting Persons beneficially owned 36.28% of that total. The table below sets forth information with respect to all purchases of shares of Common Stock of the Company by Reporting Persons since April 24, 1998, the date of the last event which required the filing of an amendment to the Schedule 13D. All of such purchases were effected by Bellingham Industries, Inc. on the Nasdaq National Market System, with the exception of the purchase of 1,363,632 shares of the Company's Common Stock on June 1, 1998 at a price of approximately $11 per share. These shares were issued in a private placement by the Company. To the Reporting Persons' best knowledge, none of the persons listed on Appendix A of the Schedule 13D effected any transaction in shares of the Company's Common Stock since April 24, 1998.
TRANSACTION NUMBER OF PRICE PER AGGREGATE DATE SHARES SHARE PRICE ----------- ---------- ------------ -------------- 4/30/98 15,000 $12-5/8 $189,375.00 1,000 $12-7/8 $12,875.00 24,000 $13 $312,000.00 6/1/98 1,363,632 $11 (approx.) $15,000,000.00
5 CUSIP NO. 744290107 13D Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. March 26, 1999 ------------------------------------ Date /s/ W.R. Gilbert ------------------------------------ Signature W.R. Gilbert, Attorney-in-fact for each of the Reporting Persons ------------------------------------ Name/Title The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute --------------------------------------------------------------------- Federal criminal violations (see 18 U.S.C. 1001). ------------------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----